Story
Urolithin A
Last updated
In one pass Urolithin A is not in the pomegranate.
Educational content, not medical advice. See a clinician about your own case.
Story path
Chapter 1
Pomegranates don't contain it
Urolithin A is not in the pomegranate. Some of the bacteria in your gut make it. Pomegranates, walnuts and some berries carry a family of plant polyphenols called ellagitannins; after you eat them, certain gut microbes have to take them apart and rebuild them into urolithin A (UA). The fruit does not hold the finished molecule.
So shelf copy that says "pomegranate fights aging" skips the microbes in the middle: without them, the same fruit does not make this molecule.
So shelf copy that says "pomegranate fights aging" skips the microbes in the middle: without them, the same fruit does not make this molecule.
Evidence · What the molecule did in animals
The idea that urolithin A drives mitophagy (the process by which a cell takes apart its own broken mitochondria) comes from Ryu 2016. The paper describes it as a natural compound that, taken by mouth, induces mitophagy both in cells and in living animals. In C. elegans worms it limited the age-related build-up of dysfunctional mitochondria and extended lifespan; in rodents it improved exercise capacity.Know its limits: these are results in worms and rodents. They are where this molecule's story starts, not a conclusion about people. Whether any of it holds in humans is the job of the two trials in What human trials measured.
How the gut microbiome works as a whole has its own story, Gut microbiome. This one follows a single metabolite.
Chapter 2
Helping cells clear broken mitochondria
Mitochondria are the cell's power plants, and as they wear they leak electrons and make reactive oxygen species (oxygen-containing molecules that damage the cell). The cell's answer is not to keep building new ones. It wraps the broken ones in a membrane bubble called an autophagosome and takes them apart for recycling — mitophagy.
Ryu 2016 saw urolithin A drive that step in cells and animals. That is a mechanism in cells and animals; what has been measured in people is molecular markers in blood and muscle, which is indirect evidence.
Ryu 2016 saw urolithin A drive that step in cells and animals. That is a mechanism in cells and animals; what has been measured in people is molecular markers in blood and muscle, which is indirect evidence.
Mechanism · A different road from NAD boosters
Urolithin A often sits on the same longevity shelf as and , but they act in different places. NMN and NR are precursors of , a cofactor that the energy-producing reactions in mitochondria depend on; taking a precursor is an attempt to top up that cofactor pool (that road is in the NMN / NR story). Urolithin A is about something else: not adding fuel to the power plants, but taking the broken plants apart. One manages the cofactor pool; the other clears out broken factories.Both roads are plausible, and both rest mainly on cells and animals. Worms living longer and rodents running farther are not yet people; what was measured in people is in What human trials measured.
Chapter 3
What human trials measured
So far, human trials have answered two things: taking urolithin A for a short time is well tolerated, and it shifts some mitochondria-related markers in blood and muscle. One secondary strength result improved, but the question that trial set out in advance to answer (its primary endpoint) did not get a yes.
So the accurate version is: something changes at the molecular level, one strength measure shows a signal, and that is a long way from showing it slows aging.
So the accurate version is: something changes at the molecular level, one strength measure shows a signal, and that is a long way from showing it slows aging.
Evidence · What each of two human trials measured
Andreux 2019 was the first trial in people: the participants were sedentary older adults, and the primary endpoint (the main question the trial set out in advance to answer) was safety. Urolithin A taken by mouth reached the plasma. At 500 mg or 1000 mg a day for four weeks, plasma acylcarnitines (the form fatty acids take while being carried into mitochondria to be burned) and the expression of a set of mitochondria-related genes in skeletal muscle both shifted. That paper did not measure strength.Singh 2022 gave a proprietary preparation (Mitopure) to middle-aged adults at two doses for four months, against placebo. In the 500 mg a day group, hamstring strength (the muscles at the back of the thigh) came out about 12% higher than placebo, but that was a secondary endpoint; peak power output (the muscle's maximal burst), the primary endpoint, did not improve significantly. The paper is industry-affiliated.
How to read it: a set of molecular markers and one secondary strength result are real. Writing anti-aging up as already shown steps over that paper's own primary endpoint.
Chapter 4
Not a longevity pill
Urolithin A is not yet an anti-aging drug. The chain you can actually assemble has four links: ellagitannins reach the gut; some people's gut microbes turn them into urolithin A; in cells and animals, it pushes cells to take apart broken mitochondria; in people, short trials found it well tolerated, with a shift in a set of molecular markers and one secondary strength improvement. None of the four links measured human lifespan.
Without that community of microbes, pomegranate juice does not make this molecule. With it, you still have not bought lifespan.
Without that community of microbes, pomegranate juice does not make this molecule. With it, you still have not bought lifespan.
Myth · The right product means the right effect
One more question often gets folded in: how much is actually in the bottle. Sandalova 2024 tested and urolithin A products on sale, comparing the measured amount with the amount on the label. That answers whether the label can be trusted, not whether this mechanism holds.So ask three things separately: does the bottle hold what the label says (product quality); what does it do in people once swallowed (so far only short trials, molecular markers and one secondary endpoint); can those changes buy a longer or healthier life (nobody has measured that). An answer to the first is not an answer to the other two.
References · 4
- Ryu, D., Mouchiroud, L., Andreux, P. A., Katsyuba, E., Moullan, N., Nicolet-dit-Felix, A. A., Williams, E. G., Jha, P., Lo Sasso, G., Huzard, D., Aebischer, P., Sandi, C., Rinsch, C., & Auwerx, J. (2016). Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nature Medicine, 22(8), 879-888. 10.1038/nm.4132
- Andreux, P. A., Blanco-Bose, W., Ryu, D., Burdet, F., Ibberson, M., Aebischer, P., Auwerx, J., Singh, A., & Rinsch, C. (2019). The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature Metabolism, 1(6), 595-603. 10.1038/s42255-019-0073-4
- Singh, A., D'Amico, D., Andreux, P. A., Fouassier, A. M., Blanco-Bose, W., Evans, M., Aebischer, P., Auwerx, J., & Rinsch, C. (2022). Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Reports Medicine, 3(5), 100633. 10.1016/j.xcrm.2022.100633
- Sandalova, E., Li, H., Guan, L., Raj, S. D., Lim, T. G., Tian, E., Kennedy, B. K., & Maier, A. B. (2024). Testing the amount of nicotinamide mononucleotide and urolithin A as compared to the label claim. GeroScience, 46(5), 5075-5083. 10.1007/s11357-024-01257-2
Written from the sources listed above. Checked sentence by sentence against them in . No physician reviews this site: it explains how the body works, and it is not medical advice. How we make content
Spotted an error, or something unclear? Email us. We read every message, check it against the sources, and fix what's wrong.